286 related articles for article (PubMed ID: 16716166)
1. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.
Wenzel J; Schmidt R; Proelss J; Zahn S; Bieber T; Tüting T
Clin Exp Dermatol; 2006 Jul; 31(4):576-82. PubMed ID: 16716166
[TBL] [Abstract][Full Text] [Related]
2. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
3. Type I interferon-associated cytotoxic inflammation in lichen planus.
Wenzel J; Scheler M; Proelss J; Bieber T; Tüting T
J Cutan Pathol; 2006 Oct; 33(10):672-8. PubMed ID: 17026519
[TBL] [Abstract][Full Text] [Related]
4. IP10/CXCL10 - CXCR3 interaction: a potential self-recruiting mechanism for cytotoxic lymphocytes in lichen sclerosus et atrophicus.
Wenzel J; Wiechert A; Merkel C; Bieber T; Tüting T
Acta Derm Venereol; 2007; 87(2):112-7. PubMed ID: 17340016
[TBL] [Abstract][Full Text] [Related]
5. CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus.
Wenzel J; Proelss J; Wiechert A; Zahn S; Bieber T; Tüting T
J Am Acad Dermatol; 2007 Apr; 56(4):648-50. PubMed ID: 17367614
[TBL] [Abstract][Full Text] [Related]
6. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets.
Wenzel J; Zahn S; Mikus S; Wiechert A; Bieber T; Tüting T
Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions.
Wenzel J; Bekisch B; Uerlich M; Haller O; Bieber T; Tüting T
Am J Clin Pathol; 2005 Jul; 124(1):37-48. PubMed ID: 15923172
[TBL] [Abstract][Full Text] [Related]
9. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA.
Wenzel J; Uerlich M; Wörrenkämper E; Freutel S; Bieber T; Tüting T
Br J Dermatol; 2005 Nov; 153(5):1011-5. PubMed ID: 16225615
[TBL] [Abstract][Full Text] [Related]
10. Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis.
Caproni M; Torchia D; Cardinali C; Volpi W; Del Bianco E; D'Agata A; Fabbri P
Br J Dermatol; 2004 Oct; 151(4):784-91. PubMed ID: 15491417
[TBL] [Abstract][Full Text] [Related]
11. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis.
Magro CM; Segal JP; Crowson AN; Chadwick P
J Cutan Pathol; 2010 Jun; 37(6):659-71. PubMed ID: 19891658
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a role of type I interferons in the pathogenesis of dermatomyositis.
Wenzel J; Scheler M; Bieber T; Tüting T
Br J Dermatol; 2005 Aug; 153(2):462-3; author reply 463-4. PubMed ID: 16086781
[No Abstract] [Full Text] [Related]
13. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus.
McNiff JM; Kaplan DH
J Cutan Pathol; 2008 May; 35(5):452-6. PubMed ID: 18005168
[TBL] [Abstract][Full Text] [Related]
15. Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches.
Wenzel J; Tüting T
Exp Dermatol; 2007 May; 16(5):454-63. PubMed ID: 17437489
[TBL] [Abstract][Full Text] [Related]
16. Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients.
Reefman E; Kuiper H; Limburg PC; Kallenberg CG; Bijl M
Ann Rheum Dis; 2008 Jan; 67(1):11-18. PubMed ID: 17502354
[TBL] [Abstract][Full Text] [Related]
17. Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions.
Chen SC; de Groot M; Kinsley D; Laverty M; McClanahan T; Arreaza M; Gustafson EL; Teunissen MB; de Rie MA; Fine JS; Kraan M
Arch Dermatol Res; 2010 Mar; 302(2):113-23. PubMed ID: 19517126
[TBL] [Abstract][Full Text] [Related]
18. Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea.
Ghoreishi M; Vera Kellet C; Dutz JP
Exp Dermatol; 2012 Jun; 21(6):417-9. PubMed ID: 22507598
[TBL] [Abstract][Full Text] [Related]
19. Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.
Fall N; Bove KE; Stringer K; Lovell DJ; Brunner HI; Weiss J; Higgins GC; Bowyer SL; Graham TB; Thornton S; Grom AA
Arthritis Rheum; 2005 Oct; 52(10):3175-80. PubMed ID: 16200621
[TBL] [Abstract][Full Text] [Related]
20. The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides.
Wenzel J; Gütgemann I; Distelmaier M; Uerlich M; Mikus S; Bieber T; Tüting T
J Am Acad Dermatol; 2005 Sep; 53(3):422-7. PubMed ID: 16112347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
